How sad doctors joke, in oncology today there are two problems: the medicines are expensive and the medicines are cheap. The meaning is clear: expensive medicines really help, but state clinics purchase them in a limited quantity, so not all patients have “miracle electricalities”. Cheap medicines, on the contrary, are accurately available to everyone, but they do not bring recovery.
The difference in prices is dizzying. For example, a drug for prostate cancer Sold In Moscow pharmacies for 193 thousand rubles (monthly course). Take it, as a rule, is necessary for life. But in the regions, doctors, not of their own free will, replace an expensive American drug with a similar domestic, but outdated medication. It helps weakly, but its monthly course costs “total” about 1300 rubles.
Representatives of the scientific community, speaking of oncology, recall the paradoxical phrase: “Cancer happens to everyone, but few live to it.” Indeed, the older the person, the more likely he will become a patient of an oncologist. By the way, the number of oncological diseases detected by cancer detected by Western Europe, in comparison with Western Europe, and Japan, is associated with this. It’s all about life expectancy: there it is much more.
Meanwhile, the treatment of even the smaller, compared to Japan, the number of cancer patients, is expensive to the state budget. Moreover, as some officials cynically notice, money is spent “nowhere.” Unfortunately, in our country, traditionally high mortality from cancer, and tendencies to its decrease are not observed. For example, in the countries of Western Europe, the USA and Japan, one of the three sick people die. In Russia, where innovative drugs are inaccessible, one person of two sick people leaves life.
The doctors themselves have repeatedly stated that the production of their own modern drugs in Russia could partially correct the situation. This is not about the so -called “generics”, copies of modern drugs that have received a patent in foreign countries. Domestic pharmaceutical producers must learn to develop and receive Western patents for their own breakthrough medicines. Or, at least, he will learn to make quality copies, selling them on the domestic market at a low price. And now the so -called “revival” of the Russian pharmaceutical industry is openly scared by many doctors.
The main problem seems to be greedy? The reason for the high cost of Western medicines is caused by large preliminary costs. In most cases, the cost of the final product is low. But, before he receives a patent for an innovative medicine, world pharmaceutical giants invest tens of millions of dollars in scientific development. Moreover, this is not one -time spending. Due to Western manufacturers of medicines, large biochemical laboratories work, in which famous scientists work. The developers of new prerogatives, using the most expensive equipment, often make a world -class scientific discoveries.
In order to recoup such high costs, medicines are often prescribed at the nah prohibitively high prices. There are truly prohibitive precedents. For example, the price of the most expensive in the world of injection (one, no longer needs) the Zulgensma drug, which cures mortal spinal-soot atrophy (SMA), Circrats in 175 million rubles. Oncological drugs are cheaper: the average retail price for the largest dosage of the anti -cancer drug It is about 506.2 thousand rubles.
Domestic pharmaceutical companies, issuing copies (generics) of foreign medications, are spent on scientists and scientific research much less. Sometimes, pharmaceutical companies are even saved on a patent. Nevertheless, domestic drug manufacturers set prices for copies of medicines not several times less than the price of original drugs. For example, the cost of packaging of one well -known drug of 10 tablets in a dosage of 80 mg is 50,341 rubles. At the same time, the same dosage of the original Western drug costs 83,333 rubles.
The inexplicable high cost of domestic “generics” is only half the problem. Russian manufacturers often make medicines by “reverse-invinging” by determining the technology of production according to the finished model of a foreign drug. But even in the case of an “honest” acquisition of a patent, our manufacturers often “lame” technology and production culture. The phrase “broken molecules” have long entered the use of doctors. This is when, due to a violation of the synthesis of the active substance, the effectiveness of the drug decreases, and the number of undesirable “side effects” is growing.
But, as the wound is saturated with “generics”, inexpensive effective drugs of purely Russian development, or produced in friendly countries, disappear from pharmacies. According to doctors, cheap medicines disappear, without which cancer patients will have nothing to treat.
For example, the so -called cytostatics (drugs for cancer patients) are in the list of vital drugs, the cost of which is controlled by the state. It is impossible to increase it. As a result, do domestic pharmaceutical companies simply refuse their production? The Ministry of Health is forced to purchase imported medicines. At the same time, for example, a widely used cyclophosphamide (cytostatic antitumor drug) is ten times more expensive for foreign manufacturers than domestic.
Simply put, it is unprofitable for Russian pharmaceutical companies to produce cheap drugs. Moderate profit does not suit the owners of private enterprises at all, most of whom have already been broken into billionaires? It is for this reason that in domestic oncobilniks today there are not enough cheap, but effective drugs that have been used in oncology for decades.
Previously, oncologists helped out the so -called “black market”? Some time ago, doctors themselves imported drugs from other countries, as in a famous film. But now the cost of medicines in the Black Market has jumped a thousand times, so patients are denied effective treatment.
According to oncologistsToday, innovative drugs receive no more than 10% of patients. The rest are treated according to standard schemes developed in 1960-1970. The protocols (schemes) of the treatment of children have not changed for more than half a century. Nobody is developing new cytostatics: their production is unprofitable. Meanwhile, these medicines could save thousands of patients.
Doctors claim that the diagnosis of cancer has ceased to be a sentence. Over the last quarter of a century, a lot has changed into oncologists. Malignant tumors are treated today using three main methods: it is surgery, radiation therapy and drug therapy. And if there are practically no problems with the first two in our country, then a crisis is observed in the field of pharmacology. Apparently, the owners of pharmacological companies forgot that their enterprises belonged to the field of medicine. Profit here is not a defining factor. Therefore, “leaching” from the market cheap effective drugs is not permissible. Apparently, the “oligarchs from pharmacy” requires “a” tablet from greed “. This, by the way, can write to them the government.
